Dashboard
1
With a growth in Net Profit of 205.5%, the company declared Outstanding results in Sep 25
- OPERATING CASH FLOW(Y) Highest at CNY 263.46 MM
- INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost
- RAW MATERIAL COST(Y) Fallen by -5.56% (YoY)
2
With ROE of 3.90%, it has a fair valuation with a 2.74 Price to Book Value
3
Market Beating Performance
Stock DNA
Pharmaceuticals & Biotechnology
CNY 4,047 Million (Small Cap)
70.00
NA
0.58%
-0.78
5.63%
2.28
Revenue and Profits:
Net Sales:
227 Million
(Quarterly Results - Sep 2025)
Net Profit:
49 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.49%
0%
-2.49%
6 Months
0.77%
0%
0.77%
1 Year
32.54%
0%
32.54%
2 Years
-19.34%
0%
-19.34%
3 Years
-13.47%
0%
-13.47%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
SWS Hemodialysis Care Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
27.59%
EBIT Growth (5y)
19.74%
EBIT to Interest (avg)
87.10
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.77
Sales to Capital Employed (avg)
0.36
Tax Ratio
7.62%
Dividend Payout Ratio
45.09%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
47.41%
ROE (avg)
6.46%
Valuation key factors
Factor
Value
P/E Ratio
70
Industry P/E
Price to Book Value
2.74
EV to EBIT
70.06
EV to EBITDA
47.55
EV to Capital Employed
8.44
EV to Sales
5.28
PEG Ratio
NA
Dividend Yield
0.50%
ROCE (Latest)
12.04%
ROE (Latest)
3.90%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
227.00
140.40
61.68%
Operating Profit (PBDIT) excl Other Income
40.00
13.60
194.12%
Interest
0.10
0.20
-50.00%
Exceptional Items
2.30
1.50
53.33%
Consolidate Net Profit
48.80
15.40
216.88%
Operating Profit Margin (Excl OI)
176.00%
55.70%
12.03%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is 61.68% vs -22.43% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is 216.88% vs -67.16% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
563.80
685.70
-17.78%
Operating Profit (PBDIT) excl Other Income
54.00
178.20
-69.70%
Interest
0.50
0.70
-28.57%
Exceptional Items
0.50
10.60
-95.28%
Consolidate Net Profit
64.00
192.20
-66.70%
Operating Profit Margin (Excl OI)
56.00%
231.00%
-17.50%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -17.78% vs 80.88% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -66.70% vs 237.79% in Dec 2023
About SWS Hemodialysis Care Co., Ltd. 
SWS Hemodialysis Care Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






